Covestor LTD Royalty Pharma PLC Transaction History

Covestor LTD

$160 Million
Q4 2024

A detailed history of Covestor LTD transactions in Royalty Pharma PLC stock. As of the latest transaction made, Covestor LTD holds 7,999 shares of RPRX stock, worth $267,326. This represents 0.13% of its overall portfolio holdings.

Number of Shares

7,999

Previous 8,326 3.93%

Holding current value

$267,326

Previous $236,000 13.56%

% of portfolio

0.13%

Previous 0.15%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$24.28 - $28.39 $7,939 - $9,283	-327 Reduced 3.93%	7,999 $204,000
Q3 2024 Nov 01, 2024	SELL	$25.63 - $29.27 $34,113 - $38,958	-1,331 Reduced 13.78%	8,326 $236,000
Q2 2024 Aug 09, 2024	BUY	$26.26 - $29.9 $24,710 - $28,135	941 Added 10.8%	9,657 $255,000
Q1 2024 May 10, 2024	BUY	$27.46 - $31.33 $168,576 - $192,334	6,139 Added 238.22%	8,716 $265,000
Q4 2023 Feb 09, 2024	BUY	$26.21 - $29.22 $35,331 - $39,388	1,348 Added 109.68%	2,577 $72,000
Q3 2023 Nov 13, 2023	BUY	$26.26 - $31.38 $5,803 - $6,934	221 Added 21.92%	1,229 $33,000
Q2 2023 Aug 11, 2023	SELL	$29.6 - $36.56 $50,793 - $62,736	-1,716 Reduced 63.0%	1,008 $31,000
Q1 2023 May 15, 2023	BUY	$32.77 - $39.4 $24,839 - $29,865	758 Added 38.56%	2,724 $98,000
Q4 2022 Feb 13, 2023	BUY	$39.17 - $44.04 $2,624 - $2,950	67 Added 3.53%	1,966 $77,000
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $75,452 - $84,477	1,892 Added 27028.57%	1,899 $76,000
Q2 2022 Aug 10, 2022	SELL	$37.53 - $44.22 $225 - $265	-6 Reduced 46.15%	7 $0
Q1 2022 May 13, 2022	SELL	$37.46 - $42.44 $37 - $42	-1 Reduced 7.14%	13 $1,000
Q4 2021 Feb 10, 2022	BUY	$35.17 - $42.48 $492 - $594	14 New	14 $1,000

Others Institutions Holding RPRX

# of Institutions

429

Shares Held

294M

Call Options Held

508K

Put Options Held

118K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $14.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account